Thursday, June 4, 2020

Genome Editing/Genome Engineering Market Set for Rapid Growth to Reach CAGR of over 14.1% by 2030 - Thermo Fisher Scientific, Lonza, Merck

Genome Editing/Genome Engineering technique are used for insertion, deletion or modify genome of a microorganism. Techniques like TALEN, CRISPR (clustered regularly interspaced palindromic repeat) and other technique are widely used in genome editing/engineering process. CRISPR-Cas9 technique is one of the most widely preferred technologies in genome editing. The global genome editing/genome engineering market is driven by technological advancements in the genomics, rising number of cancer patients, and increasing funding by government & private players in the genomics are major factors driving the market. However, ethical issue related to genome editing/genome engineering is likely to restrain the market to certain extent.

Major Key Players of the Genome Editing/Genome Engineering Market are:Thermo Fisher Scientific, Lonza, Merck, Horizon Discovery Group, Integrated DNA Technologies, New England Biolabs (US), GenScript (US), Sangamo BioSciences (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.

Read More @ http://www.sbwire.com/press-releases/genome-editinggenome-engineering-market-set-for-rapid-growth-to-reach-cagr-of-over-141-by-2030-thermo-fisher-scientific-lonza-merck-1289635.htm 


No comments:

Post a Comment